Search Results 271-280 of 17466 for sjogren

  1. Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis - Mayo Clinic

    ... Sjögren's syndrome, antisynthetase syndrome, or mixed connective tissue disease as determined by the Investigator. Secondary Sjögren's or scleroderma ...

  2. Crohn's disease - Doctors and departments - Mayo Clinic

    Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...

  3. AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This study is a placebo-controlled Phase I study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the antisense oligonucleotide ( ...

  4. Crohn's disease - Doctors and departments - Mayo Clinic

    Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...

  5. Arthritis - Doctors and departments - Mayo Clinic

    Spondyloarthritis, Sjogren's syndrome. Show more areas of focus for Anushka Irani, B.M., B.Ch., Ph.D. Atul Jain, M.D., M.S.. Internist ...

  6. Arthritis - Doctors and departments - Mayo Clinic

    Spondyloarthritis, Sjogren's syndrome. Show more areas of focus for Anushka Irani, B.M., B.Ch., Ph.D. Research Profiles. Edit search filters. close. Narrow your ...

  7. Crohn's disease - Doctors and departments - Mayo Clinic

    Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...

  8. Crohn's disease - Doctors and departments - Mayo Clinic

    Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...

  9. Crohn's disease - Doctors and departments - Mayo Clinic

    Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.

  10. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    Participants with type I autoimmune diabetes mellitus, thyroid autoimmune disease, Celiac disease, or secondary Sjögren's syndrome are not excluded -SLE ...